Response to: Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized, Controlled Trial
The Journal of Clinical Endocrinology & Metabolism · 2023
DOI: 10.1210/clinem/dgad386 ↗Kurz gefasst
Editorial in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2023. Verfasst von Anne Trinh und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Monash Health, Melbourne 3168, Australia. Hauptthemen laut MEDLINE: Cerebral Palsy, Bone Density Conservation Agents. Die Arbeit nennt 8 Literaturangaben.
Themen: Kinderkrankenpflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Endocrinology, Monash Health, Melbourne 3168, Australia.
- Centre for Endocrinology and Metabolism, Hudson Institute of Medical Research, Monash University, Melbourne 3168, Australia.
- Department of Medicine, School of Clinical Sciences, Monash University, Melbourne 3168, Australia.
ORCID-Profile: Anne Trinh
Zitieren
APA
Trinh, A., & Milat, F. (2023). Response to: Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized, Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgad386
Vancouver
Trinh A, Milat F. Response to: Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized, Controlled Trial. The Journal of Clinical Endocrinology & Metabolism. 2023. doi:10.1210/clinem/dgad386
BibTeX
@article{Trinh2023,
author = {Trinh, Anne and Milat, Frances},
title = {Response to: Zoledronate Increases Bone Mineral Density in Nonambulant Children With Cerebral Palsy: A Randomized, Controlled Trial},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2023},
doi = {10.1210/clinem/dgad386}
}
EUVIMED